Key facts
- This page summarizes Brian C. Evanko's Form 4 filing for Cigna Group (CI).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2026, 19:17.
Brian C. Evanko - 27 Feb 2026 Form 4 Insider Report for Cigna Group (CI)
- Reporting relationship
- Officer
- Issuer ticker
- CI
- Reported as of
- 27 Feb 2026
- Net transaction value
- -$1,370,751
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2026, 19:17:07 UTC
- Prior SEC filing
- 07 Oct 2025
- Next SEC filing
- 18 May 2026
- Source filing
- View source filing
- Reporting owner signature
- Tyler Gratton, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brian C. Evanko filed Form 4 for Cigna Group (CI) on 03 Mar 2026.
Change
- Previous filing in this sequence was filed on 07 Oct 2025.
- Current net transaction value: -$1,370,751.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001722909
Primary reporting owner
Evanko Brian C
- Relationship
- Officer
- Address
- 900 COTTAGE GROVE ROAD, BLOOMFIELD
- Signature
- Tyler Gratton, attorney-in-fact
- Signature date
- 02 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CI
transaction
Common Stock, $.01 Par Value
Award
- Transaction value
- $0
- Shares
- +6,428
- Change %
- +24%
- Price
- $0.000000
- Shares after
- 32,897
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
CI
transaction
Common Stock, $.01 Par Value
Award
- Transaction value
- $0
- Shares
- +9,787
- Change %
- +30%
- Price
- $0.000000
- Shares after
- 42,684
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F2
CI
transaction
Common Stock, $.01 Par Value
Tax liability
- Transaction value
- $856,611
- Shares
- -2,979
- Change %
- -7%
- Price
- $287.55
- Shares after
- 39,705
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F3
CI
transaction
Common Stock, $.01 Par Value
Tax liability
- Transaction value
- $514,139
- Shares
- -1,788
- Change %
- -4.5%
- Price
- $287.55
- Shares after
- 37,917
- Date
- 27 Feb 2026
- Ownership
- Direct
- Footnotes
- F4
CI
holding
Common Stock, $.01 Par Value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,614
- Date
- 27 Feb 2026
- Ownership
- By GRAT
- Footnotes
- F5
CI
holding
Common Stock, $.01 Par Value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 909
- Date
- 27 Feb 2026
- Ownership
- By 401(k)
- Footnotes
- F6
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CI
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +15,082
- Change %
- Price
- $0.000000
- Shares after
- 15,082
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock, $.01 Par Value
- Underlying amount
- 15,082
- Exercise price
- $287.55
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
Footnote F2
These restricted shares vest in three equal annual installments beginning March 1, 2027.
Footnote F3
Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
Footnote F4
Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
Footnote F5
Reflects the transfer by the Reporting Person of 25,614 shares of common stock on December 11, 2025 to the Reporting Person's grantor retained annuity trust.
Footnote F6
Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
Footnote F7
This option vests in three equal annual installments beginning March 1, 2027.